Literature DB >> 17475779

The molecular mechanism of hepcidin-mediated ferroportin down-regulation.

Ivana De Domenico1, Diane McVey Ward, Charles Langelier, Michael B Vaughn, Elizabeta Nemeth, Wesley I Sundquist, Tomas Ganz, Giovanni Musci, Jerry Kaplan.   

Abstract

Ferroportin (Fpn) is the only known iron exporter in vertebrates. Hepcidin, a peptide secreted by the liver in response to iron or inflammation, binds to Fpn, inducing its internalization and degradation. We show that after binding of hepcidin, Fpn is tyrosine phosphorylated at the plasma membrane. Mutants of human Fpn that do not get internalized or that are internalized slowly show either absent or impaired phosphorylation. We identify adjacent tyrosines as the phosphorylation sites and show that mutation of both tyrosines prevents hepcidin-mediated Fpn internalization. Once internalized, Fpn is dephosphorylated and subsequently ubiquitinated. An inability to ubiquitinate Fpn does not prevent hepcidin-induced internalization, but it inhibits the degradation of Fpn. Ubiquitinated Fpn is trafficked through the multivesicular body pathway en route to degradation in the late endosome/lysosome. Depletion of proteins involved in multivesicular body trafficking (Endosome Sorting Complex Required for Transport proteins), by small-interfering RNA, reduces the trafficking of Fpn-green fluorescent to the lysosome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17475779      PMCID: PMC1924807          DOI: 10.1091/mbc.e07-01-0060

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  44 in total

Review 1.  Anemia of chronic disease.

Authors:  Guenter Weiss; Lawrence T Goodnough
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

2.  Epsin is an EH-domain-binding protein implicated in clathrin-mediated endocytosis.

Authors:  H Chen; S Fre; V I Slepnev; M R Capua; K Takei; M H Butler; P P Di Fiore; P De Camilli
Journal:  Nature       Date:  1998-08-20       Impact factor: 49.962

3.  Incubation at the nonpermissive temperature induces deficiencies in UV resistance and mutagenesis in mouse mutant cells expressing a temperature-sensitive ubiquitin-activating enzyme (E1).

Authors:  H Ikehata; S Kaneda; F Yamao; T Seno; T Ono; F Hanaoka
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

4.  The molecular basis of ferroportin-linked hemochromatosis.

Authors:  Ivana De Domenico; Diane McVey Ward; Elizabeta Nemeth; Michael B Vaughn; Giovanni Musci; Tomas Ganz; Jerry Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-13       Impact factor: 11.205

5.  Human CHMP6, a myristoylated ESCRT-III protein, interacts directly with an ESCRT-II component EAP20 and regulates endosomal cargo sorting.

Authors:  Chiharu Yorikawa; Hideki Shibata; Satoshi Waguri; Kazumi Hatta; Mio Horii; Keiichi Katoh; Toshihide Kobayashi; Yasuo Uchiyama; Masatoshi Maki
Journal:  Biochem J       Date:  2005-04-01       Impact factor: 3.857

6.  Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization.

Authors:  Elizabeta Nemeth; Marie S Tuttle; Julie Powelson; Michael B Vaughn; Adriana Donovan; Diane McVey Ward; Tomas Ganz; Jerry Kaplan
Journal:  Science       Date:  2004-10-28       Impact factor: 47.728

7.  In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations.

Authors:  Lisa M Schimanski; Hal Drakesmith; Alison T Merryweather-Clarke; Vip Viprakasit; Jon P Edwards; Emma Sweetland; Judy M Bastin; Diana Cowley; Yingyong Chinthammitr; Kathryn J H Robson; Alain R M Townsend
Journal:  Blood       Date:  2005-02-03       Impact factor: 22.113

8.  The role of LIP5 and CHMP5 in multivesicular body formation and HIV-1 budding in mammalian cells.

Authors:  Diane McVey Ward; Michael B Vaughn; Shelly L Shiflett; Paul L White; Amanda L Pollock; Joshua Hill; Rachel Schnegelberger; Wesley I Sundquist; Jerry Kaplan
Journal:  J Biol Chem       Date:  2005-01-11       Impact factor: 5.157

9.  The flatiron mutation in mouse ferroportin acts as a dominant negative to cause ferroportin disease.

Authors:  Irene E Zohn; Ivana De Domenico; Andrew Pollock; Diane McVey Ward; Jessica F Goodman; Xiayun Liang; Amaru J Sanchez; Lee Niswander; Jerry Kaplan
Journal:  Blood       Date:  2007-02-08       Impact factor: 22.113

10.  Direct interaction of Cbl with pTyr 1045 of the EGF receptor (EGFR) is required to sort the EGFR to lysosomes for degradation.

Authors:  Lene Melsaether Grøvdal; Espen Stang; Alexander Sorkin; Inger Helene Madshus
Journal:  Exp Cell Res       Date:  2004-11-01       Impact factor: 3.905

View more
  147 in total

Review 1.  Diagnosis and management of iron deficiency anemia in patients with IBD.

Authors:  Jürgen Stein; Franz Hartmann; Axel U Dignass
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10-05       Impact factor: 46.802

2.  BMPER protein is a negative regulator of hepcidin and is up-regulated in hypotransferrinemic mice.

Authors:  Neeta Patel; Patarabutr Masaratana; Javier Diaz-Castro; Gladys O Latunde-Dada; Aakafa Qureshi; Pamela Lockyer; Molly Jacob; Matthew Arno; Pavle Matak; Ragai R Mitry; Robin D Hughes; Anil Dhawan; Cam Patterson; Robert J Simpson; Andrew T McKie
Journal:  J Biol Chem       Date:  2011-12-05       Impact factor: 5.157

3.  Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice.

Authors:  Ivana De Domenico; Tian Y Zhang; Curry L Koening; Ryan W Branch; Nyall London; Eric Lo; Raymond A Daynes; James P Kushner; Dean Li; Diane M Ward; Jerry Kaplan
Journal:  J Clin Invest       Date:  2010-06-07       Impact factor: 14.808

4.  Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease.

Authors:  James E Nelson; Laura Wilson; Elizabeth M Brunt; Matthew M Yeh; David E Kleiner; Aynur Unalp-Arida; Kris V Kowdley
Journal:  Hepatology       Date:  2010-11-29       Impact factor: 17.425

Review 5.  Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation.

Authors:  Chia Chi Sun; Valentina Vaja; Jodie L Babitt; Herbert Y Lin
Journal:  Am J Hematol       Date:  2012-01-31       Impact factor: 10.047

6.  Iron repletion relocalizes hephaestin to a proximal basolateral compartment in polarized MDCK and Caco2 cells.

Authors:  Seung-Min Lee; Zouhair K Attieh; Hee Sook Son; Huijun Chen; Mhenia Bacouri-Haidar; Chris D Vulpe
Journal:  Biochem Biophys Res Commun       Date:  2012-04-07       Impact factor: 3.575

7.  Benefits and risks of iron supplementation in anemic neonatal pigs.

Authors:  Paweł Lipinski; Rafał R Starzyński; François Canonne-Hergaux; Barbara Tudek; Ryszard Oliński; Paweł Kowalczyk; Tomasz Dziaman; Olivier Thibaudeau; Mikołaj A Gralak; Ewa Smuda; Jarosław Woliński; Agnieszka Usińska; Romuald Zabielski
Journal:  Am J Pathol       Date:  2010-09       Impact factor: 4.307

Review 8.  The ESCRT complexes.

Authors:  James H Hurley
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-07-23       Impact factor: 8.250

9.  Hepcidin-induced internalization of ferroportin requires binding and cooperative interaction with Jak2.

Authors:  Ivana De Domenico; Eric Lo; Diane M Ward; Jerry Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-20       Impact factor: 11.205

10.  Endogenous siderophore 2,5-dihydroxybenzoic acid deficiency promotes anemia and splenic iron overload in mice.

Authors:  Zhuoming Liu; Alieta Ciocea; L Devireddy
Journal:  Mol Cell Biol       Date:  2014-04-28       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.